Idiopathic Thrombocytopenic Purpura: Lessons from a Guideline
Authors: James N. George
Journal: Annals of Internal Medicine (1997)

Editorials15 February 1997Idiopathic Thrombocytopenic Purpura: Lessons from a GuidelineJames N. George, MD and Frank Davidoff, MD, EditorJames N. George, MDUniversity of Oklahoma Health Sciences Center, Oklahoma City, OK 73190 Annals of Internal Medicine, Philadelphia, PA 19106Search for more papers by this author and Frank Davidoff, MD, EditorUniversity of Oklahoma Health Sciences Center, Oklahoma City, OK 73190 Annals of Internal Medicine, Philadelphia, PA 19106Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-126-4-199702150-00009 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In 1994, the American Society of Hematology established a committee to explore the development of clinical guidelines on hematologic disorders; a clinical guideline on idiopathic thrombocytopenic purpura (ITP) is the initial product of this effort. The complete document was accepted by the Society in December 1995 and was published in Blood in July 1996 [1].Given that the full text has already appeared in print, why publish a shorter version of this guideline in this issue [2]?First, the whole point of creating and distributing clinical guidelines is to bring the widest possible consistency and rationality to the diagnosis and ...References1. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996; 88:3-40. Google Scholar2. Diagnosis and treatment of idiopathic thrombocytopenic purpura: recommendations of the American Society of Hematology. The American Society of Hematology ITP Practice Guideline Panel. Ann Intern Med. 1997; 126:319-26. Google Scholar3. Woolf SH. Practice guidelines: a new reality in medicine. III. Impact on patient care. Arch Intern Med 1996; 153:2646-55. Google Scholar4. Tunis SR, Hayward RS, Wilson MC, Rubin HR, Bass EB, Johnston M, et al. Internists' attitudes about clinical practice guidelines. Ann Intern Med. 1994; 120:956-63. Google Scholar5. Cook DJ, Guyatt GH, Laupacis A, Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest. 1992; 102:3055-115. Google Scholar6. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized, controlled trials. The CONSORT statement. JAMA. 1996; 276:637-9. Google Scholar7. Mulrow CD. The medical review article: state of the science. Ann Intern Med. 1987; 106:485-8. Google Scholar Author, Article, and Disclosure InformationAuthors: James N. George, MD; Frank Davidoff, MD, EditorAffiliations: University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190 Annals of Internal Medicine, Philadelphia, PA 19106Corresponding Author: James N. George, MD, Hematology-Oncology Section, University of Oklahoma Health Sciences Center, PO Box 26901, Oklahoma City, OK 73190.Current Author Addresses: Dr. George: Hematology-Oncology Section, University of Oklahoma Health Sciences Center, PO Box 26901, Oklahoma City, OK 73190. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoDiagnosis and Treatment of Idiopathic Thrombocytopenic Purpura: Recommendations of the American Society of Hematology Metrics Cited byBleeding severity as an important outcome in childhood immune thrombocytopeniaTreatment Options for Chronic Refractory Idiopathic Thrombocytopenic Purpura in Adults: Focus on Romiplostim and EltrombopagA positive antinuclear antibody test predicts for a poor response to initial steroid therapy in adults with idiopathic thrombocytopenic purpuraGerinnungsstörungen in der GeburtshilfeA prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study groupIdiopathic thrombocytopenic purpura of childhood: A problem-oriented review of the managementDiagnosis and Treatment of Idiopathic Thrombocytopenic PurpuraIntravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trialInitial management of immune thrombocytopenic purpura in children: Is supportive counseling without therapeutic intervention sufficient?Treatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura in a mouse modelTreatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura in a mouse modelEVIDENCE-BASED MEDICINEEvidence and ethicsGenetic origin of IgG antibodies cloned by phage display and anti-idiotypic panning from three patients with autoimmune thrombocytopeniaIdiopathic Thrombocytopenic Purpura: Diagnosis and ManagementIdiopathic Thrombocytopenic Purpura: Diagnosis and ManagementSuccessful treatment of severe refractory idiopathic thrombocytopenic purpura with liposomal doxorubicinIdiopathic thrombocytopenic purpura: a guideline for diagnosis and management of children and adultsClinical Decisions in Idiopathic Thrombocytopenic PurpuraGerinnungsstörungen in der Geburtshilfe 15 February 1997Volume 126, Issue 4Page: 317-318KeywordsClinical trial reportingClinical trialsForecastingHematology and oncologyHemorrhageIdiopathic thrombocytopenic purpuraPatientsPediatricsPlateletsTreatment guidelines ePublished: 15 August 2000 Issue Published: 15 February 1997 Copyright & PermissionsCopyright © 1997 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...